Magnitude Biosciences raises $1.6M
Magnitude Biosciences announced a Seed round of $1.6M on 15 September 2026. The company operates in HealthTech and is based in United Kingdom. It was founded by Fozia Saleem, CEO. Announced 3 days ago.
Founder
Fozia Saleem
CEO, Magnitude Biosciences
Outreach angles
- -Dr. Fozia Saleem leads Magnitude Biosciences, a Durham University spinout she built into a working contract research organisation.
- -She has positioned the company's VivoScan platform around whole-organism compound screening, a niche high-throughput drug discovery method.
- -The new funding, which includes an Innovate UK Investor Partnership grant, will accelerate commercialisation of VivoScan for drug discovery clients.
Signals
SeedHealthcareDeep TechB2BRevenue-Generating
Round details
Company: Magnitude Biosciences
Domain: magnitudebiosciences.com
Amount: $1.6M
Stage: Seed
Industry: HealthTech
Country: United Kingdom
Announced: 15 September 2026
Other HealthTech raises
Recently funded in United Kingdom